Eye Health

Age-related macular degeneration (ARMD) is the most common cause of blindness today. The disease leads to a gradual loss of sharp vision, making everyday activities increasingly problematic.

ARMD is a disease of the retina, which is the tissue in the human body with the highest concentration of DHA. It has been shown that people with a regular intake of seafood containing significant amounts of the Omega-3 fatty acid DHA have a lower risk of developing ARMD than those who do not eat fish.

Scientists believe that DHA can alleviate symptoms in patients with ARMD, and EPAX 1050 TG is currently being used in two ongoing clinical studies of patients with ARMD.


Click here to see articles about Omega-3 and Eye Health

 
 

EPAX 1050 TG

60 mg/g EPA
430 mg/g DHA

EPAX 1050 TG Specification
 EPAX 1050 TG Nutritional values

 

 
 
EPAX News & Events

Epax phase-3 study builds base for continued expansion into pharmaceutical omega-3 segment

Epax AS continues expansion into the pharmaceutical omega-3 segment with study
on AKR963 successfully achieving phase 3 study efficacy endpoints.

Read Press Release

 
 

EPAX Announces Corporate Restructuring

The Omega-3 lipids corporation previously formed by Trygg Pharma and former EPAX AS will be named EPAX AS. Former EPAX AS will become Epax Norway AS, a fully owned subsidiary and the key operating company of the Epax group.

Read press release

 
 

EPAX again honored as top supplier by Banner Pharmacaps.

EPAX AS was recognized for on-time deliveries and high quality standards.

Read press release

 
 
EPAX AS
PO Box 2047
NO-6028 Aalesund, Norway

Site Map    •    Disclaimer

© Copyright 2008  EPAX AS

Tlf: +47 70 13 59 60
Fax: +47 70 13 59 61
E-mail: epax@epax.com
sales@epax.com